INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 24, 2026...
Day: March 24, 2026
Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology...
Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company’s Scientific Advisory Board
-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision Cancer Therapies -- SOUTH...
LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Launched VIZZ® (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of...
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
SEATTLE, March 24, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...
Hyperion DeFi Enters HAUS Agreement with Silhouette
Latest DeFi Monetization Agreement Generates Scalable Revenues and Ecosystem Rewards in Partnership with Private Trading Infrastructure on HyperliquidLAGUNA HILLS, Calif.,...
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p<...
Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026
WAYNE, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella” or “the Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company...
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism – Strong Interest Already Building
Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through...
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
Grant in China marks a major milestone in global IP strategy, advancing protection of its VIVI Box platform across key...
Promino Advances Rejuvenate Platform as Muscle Health Emerges as High-Growth Functional Beverage Category
Focused execution across retail, e-commerce and product innovation to scale a differentiated muscle health platformBurlington, Ontario--(Newsfile Corp. - March 24,...
GCC Wearable Health Devices Market to Witness 14.7% CAGR, Surpassing USD 3.12 Billion by 2032, Says MarkNtel Advisors
NEW DELHI, March 24, 2026 /PRNewswire/ -- According to the in-depth market research report published by MarkNtel Advisors, the Wearable Health...
BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
CARLSBAD, Calif., March 23, 2026 /PRNewswire/ -- mymediset today announced the launch of mymediAI, a new agentic AI capability designed...